Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Novastan granted priority review status by FDA

Sep. 9, 1997

T-686 inhibits thrombus formation without hemostatic impairment

Sep. 5, 1997

RPR scientists try a new approach to gpIIb/IIIa antagonists

Sep. 5, 1997

DuPont Merck discloses new anticoagulants

Sep. 4, 1997

Reteplase is superior to alteplase in pulmonary embolism

Sep. 2, 1997

New inhibitors of platelet aggregation from Taiwan

Sep. 2, 1997

Spotlight on fibrinogen antagonists

Sep. 2, 1997

TNK-tPA as effective as tPA, studies show

Aug. 27, 1997

PRISM-PLUS results on tirofiban released

Aug. 27, 1997

Initial PURSUIT trial results presented in Stockholm

Aug. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026